# US 2026/0216240 A1 · Anti-inflammatory composition comprising colloidal silver and plant extracts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0216240 A1
- Document ID: US20260216240A1
- Status: Published application
- Kind: A1
- Application number: 19/151,896
- Filed: 2024-01-31
- Published: 2026-07-30
- Earliest claimed: 2023-01-31
- Assignees: Bobs Silver
- Applicants: Bobs Silver
- Inventors: Sadek BAITI
- Web page: https://patentgrep.com/patent/US20260216240A1

## CPC

- A61K 33/38: Silver; Compounds thereof
- A61K 8/19: containing inorganic ingredients
- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 35/644: Beeswax; Propolis; Royal jelly; Honey
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/282: Artemisia, e.g. wormwood or sagebrush
- A61K 36/38: Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
- A61K 36/8962: Allium, e.g. garden onion, leek, garlic or chives
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61Q 19/00: Preparations for care of the skin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention relates to a composition for use as medication in inflammation prophylaxis and/or treatment comprising at least silver in colloidal form, Sambucus Nigra extract, Primulae flos cum calycibus extract and/or Hypericum perforatum extract, and Pelargonium sidoides extract. According to an embodiment, said composition is used for prophylaxis and/or treatment of Staphylococcus aureus-inducedl inflammation.

## Claims

### Claim at position 1

1-10. (canceled)

### Claim 11

A composition for prophylaxis and/or treatment of inflammation comprising:
silver in colloidal form;
sambucus nigra extract;
hypericum perforatum extract; and
pelargonium sidoides extract.

### Claim 12 (depends on 11)

A composition according to claim 11, wherein said silver in colloidal form has a particle size between 0.1 and 30 nanometers.

### Claim 13 (depends on 11)

A composition according to claim 11, wherein the composition comprises:
between 20 mg and 250 mg of the silver in colloidal form per liter of the composition;
between 0.3 and 5% by weight of the sambucus nigra extract composition;
between 0.5 and 11% by weight of the hypericum perforatum extract composition; and
between 1 and 6% by weight of the pelargonium sidoides extract composition.

### Claim 14 (depends on 11)

A composition according to claim 11, further comprising silver in ionic form.

### Claim 15 (depends on 14)

A composition according to claim 14, wherein the composition comprises:
between 20 mg and 250 mg of total silver per liter of composition, distributed as:
between 70 and 99.99% of the silver in colloidal form by total weight of said silver; and
between 0.01 and 30% of the silver in ionic form by total weight of said silver;
between 0.3 and 5% by weight of the sambucus nigra extract composition;
between 0.5 and 11% by weight of the hypericum perforatum extract composition; and
between 1 and 6% by weight of the pelargonium sidoides extract composition.

### Claim 16 (depends on 11)

A composition according to claim 11, further comprising:
echinacea extract; and/or
propolis, and/or
artemisia extract and/or
allium sativum extract and/or allium
primulae flos cum calycibus extract.

### Claim 17 (depends on 16)

A composition according to claim 16, wherein the composition comprises:
between 0.01 and 8% by weight of the echinacea extract composition, and/or
between 0.01 and 7% by weight of the propolis composition, and/or
between 0.5 and 3% by weight of the artemisia extract composition, and/or
between 0.01 and 10% by weight of the allium sativum extract composition, and/or
between 1 and 9% by weight of the primulae flos cum calycibus extract composition.

### Claim 18 (depends on 11)

A composition according to claim 11 wherein the composition is in the form of an ointment, cream, liquid solution, patch or gel.

### Claim 19

A method for prophylaxis and/or treatment of inflammation comprising administering to a subject in need thereof a composition comprising:
silver in colloidal form;
sambucus nigra extract;
hypericum perforatum extract; and
pelargonium sidoides extract.

### Claim 20 (depends on 19)

A method according to claim 19, wherein said silver in colloidal form has a particle size between 0.1 and 30 nanometers.

### Claim 21 (depends on 19)

A method according to claim 19, wherein said composition comprises:
between 20 mg and 250 mg of the silver in colloidal form per liter of the composition;
between 0.3 and 5% by weight of the sambucus nigra extract composition;
between 0.5 and 11% by weight of the hypericum perforatum extract composition; and
between 1 and 6% by weight of the pelargonium sidoides extract composition.

### Claim 22 (depends on 19)

A method according to claim 19, wherein the composition further comprises silver in ionic form.

### Claim 23 (depends on 22)

A method according to claim 22, wherein the composition comprises:
between 20 mg and 250 mg of total silver per liter of composition, distributed as:
between 70 and 99.99% of the silver in colloidal form by total weight of said silver; and
between 0.01 and 30% of the silver in ionic form by total weight of said silver;
between 0.3 and 5% by weight of the sambucus nigra extract composition;
between 0.5 and 11% by weight of the hypericum perforatum extract composition; and
between 1 and 6% by weight of the pelargonium sidoides extract composition.

### Claim 24 (depends on 19)

A method according to claim 19, wherein the composition further comprises:
echinacea extract; and/or
propolis, and/or
artemisia extract and/or
allium sativum extract and/or
primulae flos cum calycibus extract.

### Claim 25 (depends on 24)

A method according to claim 24, wherein the composition comprises:
between 0.01 and 8% by weight of the echinacea extract composition, and/or
between 0.01 and 7% by weight of the propolis composition, and/or
between 0.5 and 3% by weight of the artemisia extract composition, and/or
between 0.01 and 10% by weight of the allium sativum extract composition, and/or
between 1 and 9% by weight of the primulae flos cum calycibus extract composition.

### Claim 26 (depends on 19)

A method according to claim 19 wherein said inflammation is Staphylococcus aureus-induced inflammation.

### Claim 27 (depends on 19)

A method according to claim 19 wherein the method comprises applying the composition to the skin in the form of an ointment, cream, liquid solution, patch or gel.

### Claim 28

A cosmetic treatment method for reducing the visual signs of inflammation in a subject, comprising administering to the subject a composition comprising:
silver in colloidal form;
sambucus nigra extract;
hypericum perforatum extract; and
pelargonium sidoides extract.
